TM7SF2 is an essential molecule involving in the activation of C-Raf-ERK pathway and then promotes cell growth and inhibited apoptosis in cervical cancer (Fig. 8), indicating that inhibition of TM7SF2 may be a therapeutic strategy in the future for cervical cancer patients. This evidence concerns the gene RAF1 and cervical carcinoma.